PHILADELPHIA CHROMOSOME POSITIVE
Clinical trials for PHILADELPHIA CHROMOSOME POSITIVE explained in plain language.
Never miss a new study
Get alerted when new PHILADELPHIA CHROMOSOME POSITIVE trials appear
Sign up with your email to follow new studies for PHILADELPHIA CHROMOSOME POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo shows promise against tough leukemia
Disease control OngoingThis study tests a powerful chemotherapy regimen (Hyper-CVAD) combined with the targeted drug ponatinib in people with a specific type of acute lymphoblastic leukemia (ALL) that has a genetic change called the Philadelphia chromosome. The goal is to see if this combination can be…
Matched conditions: PHILADELPHIA CHROMOSOME POSITIVE
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 09:23 UTC
-
Engineered immune cells take on tough blood cancers
Disease control OngoingThis early-stage study tests a treatment made from a patient's own immune cells, modified to recognize and attack cancer cells that have returned or not responded to standard therapy. The treatment is given with chemotherapy and an immune-boosting drug. The main goals are to chec…
Matched conditions: PHILADELPHIA CHROMOSOME POSITIVE
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated May 26, 2026 09:01 UTC
-
New combo therapy shows promise against tough leukemia
Disease control OngoingThis study tests whether adding blinatumomab to standard targeted therapy (TKI) can better treat adults with a specific type of leukemia (Ph+ ALL). About 17 participants will receive the drug combination after initial treatment. The goal is to see if more patients achieve a deep …
Matched conditions: PHILADELPHIA CHROMOSOME POSITIVE
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
Massive trial seeks best chemo combo for young leukemia patients
Disease control OngoingThis large phase 3 study is testing different combinations and doses of chemotherapy drugs in over 9,000 children and young adults newly diagnosed with standard-risk B-cell acute lymphoblastic leukemia or localized B-cell lymphoblastic lymphoma. The goal is to find which treatmen…
Matched conditions: PHILADELPHIA CHROMOSOME POSITIVE
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC